A yeast-based immunotherapy against clostridioides difficile infection

Ended Project Grant Awarded Last action

Award ID
R44AI155277
Recipient
Awarding agency
Obligated
$7,324,036

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $6,769,681.00 Federal
  • $554,355.00 Non-federal
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $906,503 $0
Amendment $906,503 $0
Amendment $906,503 $0
Amendment $906,503 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $932,749 $0
Amendment $932,749 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $16,732 $0
Amendment $16,732 $16,732
Amendment $537,623 $0
Amendment $537,623 $537,623
Amendment $0 $0
Original award $169,461 $0
Show all 25

Quick answers

Who received award R44AI155277?

R44AI155277 was awarded to Fzata Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2020.

How much is award R44AI155277 worth?

$7,324,036 has been obligated on R44AI155277: $6,769,681 in federal funding and $554,355 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award